Format

Send to

Choose Destination
Leukemia. 2017 Jan;31(1):237-240. doi: 10.1038/leu.2016.250. Epub 2015 Aug 30.

NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors.

Author information

1
Children's Cancer Research Institute, Vienna, Austria.
2
CeMM, Research Center for Molecular Medicine of the Austrian Academy of Science, Vienna, Austria.
3
Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
4
Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
5
Department of Pediatric Hemato-Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
6
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
7
Department of Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany.
8
Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
9
Division of Hematology and Hemostaseology, Department of Internal Medicine, Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
10
St Anna Children's Hospital, Vienna, Austria.
11
Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
PMID:
27573554
PMCID:
PMC5220134
DOI:
10.1038/leu.2016.250
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center